Clinical trial
Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
NCT01746251
Study timeline
Study start (unknown)2013-01-01Date precision: month
Registry last updated2020-07-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancerunresolved
Interventions
AfatinibDRUG · verified · RxNorm: afatinib
Sponsors & collaborators
Massachusetts General Hospitallead sponsor
National Comprehensive Cancer Networkcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01746251 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.